Durvalumab plus Tremelimumab for the Treatment of Patients (pts) with Advanced Neuroendocrine Neoplasms (NENs) of Lung or Gastroenteropancreatic (GEP) Origin. A Phase II Multicohort Trial (DUNE Trial / GETNE 1601)

J. Hernando-Cubero, J. L. Manzano, M. Benavent,C. Lopez, R. Teule,R. Garcia-Carbonero,A. Carmona-Bayonas,G. Crespo, A. Cubillo, P. Jimenez-Fonseca, A. LaCasta,J. Capdevila

NEUROENDOCRINOLOGY(2018)

引用 0|浏览0
暂无评分
关键词
durvalumab,tremelimumab,neuroendocrine,immunotherapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要